Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Acinetobacter Infections | 2 | 2026 | 6 | 1.850 |
Why?
|
| Acinetobacter baumannii | 2 | 2026 | 6 | 1.850 |
Why?
|
| Bacterial Vaccines | 1 | 2026 | 3 | 0.990 |
Why?
|
| Bacterial Toxins | 1 | 2026 | 6 | 0.980 |
Why?
|
| Bacterial Proteins | 1 | 2026 | 10 | 0.980 |
Why?
|
| Biofilms | 1 | 2024 | 3 | 0.870 |
Why?
|
| Bacteremia | 1 | 2024 | 8 | 0.870 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2024 | 2 | 0.860 |
Why?
|
| Pseudomonas Infections | 1 | 2024 | 2 | 0.860 |
Why?
|
| Phylogeny | 1 | 2024 | 20 | 0.850 |
Why?
|
| Epitopes, T-Lymphocyte | 2 | 2026 | 2 | 0.460 |
Why?
|
| Humans | 7 | 2026 | 6794 | 0.330 |
Why?
|
| Secretory Pathway | 1 | 2008 | 1 | 0.290 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2008 | 9 | 0.290 |
Why?
|
| Cell Differentiation | 1 | 2008 | 101 | 0.280 |
Why?
|
| Epitope Mapping | 1 | 2026 | 1 | 0.250 |
Why?
|
| Antigens, Bacterial | 1 | 2026 | 2 | 0.250 |
Why?
|
| Quorum Sensing | 1 | 2024 | 1 | 0.220 |
Why?
|
| Virulence | 1 | 2024 | 5 | 0.220 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2024 | 1 | 0.220 |
Why?
|
| Pseudomonas Vaccines | 1 | 2024 | 1 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 1 | 2024 | 73 | 0.210 |
Why?
|
| Animals | 1 | 2024 | 1875 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 11 | 3 | 2005 | 4 | 0.150 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2005 | 92 | 0.110 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2005 | 8 | 0.100 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2002 | 19 | 0.090 |
Why?
|
| Calnexin | 1 | 2008 | 1 | 0.070 |
Why?
|
| Golgi Apparatus | 1 | 2008 | 2 | 0.070 |
Why?
|
| RNA Interference | 1 | 2008 | 11 | 0.070 |
Why?
|
| Monocytes | 1 | 2008 | 14 | 0.070 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 21 | 0.070 |
Why?
|
| Cell Line | 1 | 2008 | 124 | 0.070 |
Why?
|
| Physical Chromosome Mapping | 1 | 2005 | 1 | 0.060 |
Why?
|
| Chromosome Deletion | 1 | 2002 | 6 | 0.050 |
Why?
|
| DNA, Neoplasm | 1 | 2002 | 6 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2000 | 2 | 0.040 |
Why?
|
| HeLa Cells | 3 | 2005 | 15 | 0.040 |
Why?
|
| Hybrid Cells | 2 | 2002 | 4 | 0.020 |
Why?
|
| Neoplasm Proteins | 2 | 2002 | 18 | 0.020 |
Why?
|
| Female | 3 | 2005 | 4060 | 0.020 |
Why?
|
| Centromere | 1 | 2002 | 1 | 0.010 |
Why?
|
| Metaphase | 1 | 2002 | 1 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 1 | 0.010 |
Why?
|
| Loss of Heterozygosity | 1 | 2002 | 1 | 0.010 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2002 | 2 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2002 | 3 | 0.010 |
Why?
|
| Microsatellite Repeats | 1 | 2002 | 2 | 0.010 |
Why?
|
| Karyotyping | 1 | 2002 | 5 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2002 | 10 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 15 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 23 | 0.010 |
Why?
|
| Endometrium | 1 | 2002 | 24 | 0.010 |
Why?
|
| Multiple Endocrine Neoplasia Type 1 | 1 | 2000 | 1 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2000 | 19 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 2000 | 72 | 0.010 |
Why?
|
| Mutation | 1 | 2000 | 97 | 0.010 |
Why?
|